Filing Details
- Accession Number:
- 0001214659-16-014639
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-11-14 18:20:19
- Reporting Period:
- 2016-11-09
- Filing Date:
- 2016-11-14
- Accepted Time:
- 2016-11-14 18:20:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1649989 | Oncobiologics Inc. | ONS | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1227041 | J Stephen Mcandrew | C/O Oncobiologics, Inc. 7 Clarke Drive Cranbury NJ 08512 | Svp Bus. Strat. & Dev. | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Restricted Stock Units | Disposition | 2016-11-09 | 57,971 | $0.00 | 0 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2016-11-09 | 57,971 | $0.00 | 57,971 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-11-11 | 21,367 | $3.75 | 36,604 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Footnotes
- Granted pursuant to the Issuer's 2015 Equity Incentive Plan.
- Each restricted stock unit ("RSU") represents the right to receive, at settlement, one (1) share of the Issuer's common stock.
- The RSUs vest upon the first to occur of (x) a change of control as defined in the award agreement and (y) the expiration of the 6 month lock-up period following the Issuer's initial public offering, in each case subject to continued service through such event.
- Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on November 9, 2016. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person.